Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie W Lees

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Journal of Crohn'S & Colitis|December 2, 2015
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel DiseaseGraham A Heap, Kenji So, Mike Weedon, et al.
Nature|April 30, 2025
Global evolution of inflammatory bowel disease across epidemiologic stagesLindsay Hracs, Joseph W Windsor, Julia Gorospe, et al.
Nature Genetics|November 25, 2010
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociAndre Franke, Dermot P B McGovern, Jeffrey C Barrett, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring studyNeil Chanchlani, Simeng Lin, Marcus K Auth, et al.
Nature|November 7, 2012
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseLuke Jostins, Stephan Ripke, Rinse K Weersma, et al.
Nature Genetics|February 8, 2011
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47Carl A Anderson, Gabrielle Boucher, Charlie W Lees, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Journal of Crohn'S & Colitis|December 2, 2015
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel DiseaseGraham A Heap, Kenji So, Mike Weedon, et al.
Nature|April 30, 2025
Global evolution of inflammatory bowel disease across epidemiologic stagesLindsay Hracs, Joseph W Windsor, Julia Gorospe, et al.
Nature Genetics|November 25, 2010
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociAndre Franke, Dermot P B McGovern, Jeffrey C Barrett, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring studyNeil Chanchlani, Simeng Lin, Marcus K Auth, et al.
Nature|November 7, 2012
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseLuke Jostins, Stephan Ripke, Rinse K Weersma, et al.
Nature Genetics|February 8, 2011
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47Carl A Anderson, Gabrielle Boucher, Charlie W Lees, et al.
Pageof 10